A comparison of clinical outcomes from ZUMA-5 and the international scholar-5 external control cohort in R/R FL
A comparison of clinical outcomes from ZUMA-5 and the international scholar-5 external control cohort in R/R FL
Clinically sufficient vitamin D levels at breast cancer diagnosis and survival outcomes
Afamitresgene autoleucel (Formerly ADP-A2M4) in patients with advanced synovial sarcoma or myxoid/round cell liposarcoma
AL3818 hydrochloride monotherapy in subjects with metastatic or advanced synovial sarcoma
CAPTIVATE: Fixed-duration first-line treatment with ibrutinib plus venetoclax for CLL/SLL
CHRONOS: Anti-EGFR rechallenge therapy with panitumumab driven by ctDNA molecular selection in mCC
Adjuvant chemo following chemoradiation as treatment for locally advanced cervical cancer compared to chemoradiation alone
HCRN GU 16-257: Phase 2 trial of gemcitabine, cisplatin, plus nivolumab with selective bladder sparing in MIBC patients
LEAP-004: Lenvatinib + pembrolizumab for patients with advanced melanoma and confirmed progression on a PD-1 or PD-L1 inhibitor
OncoAlert and ecancer ASCO roundup - Day 3
PANAMA: Maintenance 5FU/LV plus panitumumab or 5FU/LV alone in RAS wildtype mCRC
OncoAlert and ecancer ASCO roundup - Day 2